Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2562-2020Class I

BodyGuard Microset, REF: A120-161XYB

CME America, LLC / initiated 2020-06-16 / Terminated / root cause: design

CME America, LLC began a recall of BodyGuard Microset, REF: A120-161XYB on . FDA classified it as Class I and gives the reason as "Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy". As of , the recall status on record is Terminated, and MDM tags the root cause as design.

Recall record

Recall number
Z-2562-2020
Classification
Class I
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
CME America, LLC
Product
BodyGuard Microset, REF: A120-161XYB
Product code
FPA Set, Administration, Intravascular
Reason for recall
Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy
Root cause tag
design
FDA root cause
Device Design
Action
On 06/16/20, Urgent Medical Device Recall Correction and Removal notices were emailed and mailed to customers and distributors. These notices provided additional information about the administration sets that were first identified in another recall notification issued on 04/27/20: www.bd.com/en-us/support/recall-notifications/recall-notification---cme-america-bodyguard-infusion-pump-system Customers ere asked to take the following immediate actions: 1) Share this letter with all users of the product within your facility to ensure awareness and understanding of this notice. 2) Identify any remaining inventory of infusion sets in Category C and D, document the infusion sets on the Customer Response Form, and discard following your institution s policy for destruction. 3) Identify any remaining inventory of infusion sets in Category B and document that on the Customer Response Form. Labels stating, in part, do not use for flow rates greater-than 500mL/hr, will be provided upon receipt of response forms, so customers may affix them to those devices. The quantity of Category A sets should be noted on the response form. Category A sets can be used for non-critical medications where plus/minus 13% accuracy does not adversely impact patients. There is no flow rate restriction for these sets. The recalling firm is suspending further distribution of the infusion pump system until further notice and will remove these products from the U.S. market. The firm will work with customers to facilitate a smooth transition away from the product. A supply of infusion sets in Category A and Category B will be maintained to support the Infusion Pumps remaining at facilities until the removal or disposal of pump(s) is complete. Distributors were asked to email customer lists to the recalling firm so the recalling firm can notify these customers directly. Customers with additional questions were encouraged to call Customer/Technical Support at 877-263-0111 between 8AM to 5PM MDT.
Quantity in commerce
25746
Distribution
U.S: CA, IN, LA, MO, FL, IL, ME, MN, CO, VA, OK, NE, GA, AL, KY, IA, MS, ID, TX, SC, OH, SD, NV, MI, WY, NC, PA, TN, KS, NJ, OR, AR, NM, MA, NY, DC, RI, MD, WA, WI, AZ, NH, UT, HI, AK, MT, ND, VT, CT. OUS (Foreign): Canada, UK
Product codes and lots
All lots within expiry

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2562-2020
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2553-2020Class ITerminatedVoluntary: Firm initiated
Z-2554-2020Class ITerminatedVoluntary: Firm initiated
Z-2555-2020Class ITerminatedVoluntary: Firm initiated
Z-2556-2020Class ITerminatedVoluntary: Firm initiated
Z-2557-2020Class ITerminatedVoluntary: Firm initiated
Z-2558-2020Class ITerminatedVoluntary: Firm initiated
Z-2559-2020Class ITerminatedVoluntary: Firm initiated
Z-2560-2020Class ITerminatedVoluntary: Firm initiated
Z-2561-2020Class ITerminatedVoluntary: Firm initiated
Z-2562-2020Class ITerminatedVoluntary: Firm initiated
Z-2563-2020Class ITerminatedVoluntary: Firm initiated
Z-2564-2020Class ITerminatedVoluntary: Firm initiated
Z-2565-2020Class ITerminatedVoluntary: Firm initiated
Z-2566-2020Class ITerminatedVoluntary: Firm initiated
Z-2567-2020Class ITerminatedVoluntary: Firm initiated
Z-2568-2020Class ITerminatedVoluntary: Firm initiated
Z-2569-2020Class ITerminatedVoluntary: Firm initiated
Z-2570-2020Class ITerminatedVoluntary: Firm initiated
Z-2571-2020Class ITerminatedVoluntary: Firm initiated
Z-2572-2020Class ITerminatedVoluntary: Firm initiated
Z-2573-2020Class ITerminatedVoluntary: Firm initiated
Z-2574-2020Class ITerminatedVoluntary: Firm initiated
Z-2575-2020Class ITerminatedVoluntary: Firm initiated
Z-2576-2020Class ITerminatedVoluntary: Firm initiated
Z-2577-2020Class ITerminatedVoluntary: Firm initiated
Z-2578-2020Class ITerminatedVoluntary: Firm initiated
Z-2579-2020Class ITerminatedVoluntary: Firm initiated
Z-2580-2020Class ITerminatedVoluntary: Firm initiated
Z-2581-2020Class ITerminatedVoluntary: Firm initiated
Z-2582-2020Class ITerminatedVoluntary: Firm initiated
Z-2583-2020Class ITerminatedVoluntary: Firm initiated
Z-2584-2020Class ITerminatedVoluntary: Firm initiated
Z-2585-2020Class ITerminatedVoluntary: Firm initiated
Z-2586-2020Class ITerminatedVoluntary: Firm initiated
Z-2587-2020Class ITerminatedVoluntary: Firm initiated
Z-2588-2020Class ITerminatedVoluntary: Firm initiated
Z-2589-2020Class ITerminatedVoluntary: Firm initiated